Skip to main content

Arteriovenous Malformation Market is Growing Dynamically at a Healthy CAGR of 6.1% During Forecast to 2023

Market Synopsis:
The increasing support and rising investments for research & development activities are likely to intensify the competitive landscape of the arteriovenous malformation market in the forthcoming years. Additionally, the need for better treatment facilities is another major factor favoring the growth of the market. AVM is mostly hereditary, although it can be developed in later life too, and the need for its treatment has increased with the rising awareness about the disease.
Market Research Future (MRFR)’s latest report projects that the global Arteriovenous Malformation Treatment Market Size is set to expand at 6.1% CAGR during the forecast period 2017 to 2023. The developments and innovations introduced in the healthcare sector have intensified the competition in the market. There are several types of Arteriovenous Malformations (AVM), such as occult or cryptic AVM or cavernous malformations, true arteriovenous malformation, and others. The industry leaders endeavor to develop customized and effective medical facilities for each of these types which is likely to fuel demand in the market.
Competitive Dashboard:
  • Toshiba Medical Systems Corporation
  • Nihon Kohden Corporation
  • Electrical Geodesics Inc
  • Carestream Health
  • Fujifilm Holdings
  • Siemens Healthcare
  • Philips Healthcare
  • GE Healthcare
  • Shimadzu Corporation
  • Hologic
  • Masimo Corporation
Market Segmentation:
  • By type, the global arteriovenous malformation market is segmented into true arteriovenous malformation, occult or cryptic AVM or cavernous malformations, venous malformation, hemangioma, and dural fistula.
  • By diagnosis, the arteriovenous malformation market has been segmented into physical examination, blood test, brain scans, and others. The brain scan segment is further sub-segmented into Computerized Tomography (CT) scan, Magnetic Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA), and Electroencephalography (EEG).
  • By treatment, the global arteriovenous malformation market is segmented into endovascular embolization, neurosurgery, and
  • By end-user, the arteriovenous malformation market has been segmented into hospitals & clinics, research laboratories, and
Regional Analysis:
By region, the global arteriovenous malformation market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas dominate the global market currently and is expected to exhibit substantial growth in the forthcoming years. The growth can be ascribed to the factors such as high health care spending, developed healthcare technology, rising R&D activities, increasing patient pool, and presence of key players among others.
Europe is the second largest market for arteriovenous malformation. The factors responsible for favoring the expansion of the regional arteriovenous malformation market are government support and the availability of funds for research & development activities. Furthermore, the concentration of developed economies is likely to propel the growth of the arteriovenous malformation market over the next couple of years.
Asia Pacific is projected to be the fastest growing regional market owing to rapid developments in healthcare facilities. Meanwhile, the Middle East & Africa is prognosticated to account for the least share in the arteriovenous malformation market due to poor socio-economic condition prevailing in African regions.
Industry News:
In March 2018, Canon Medical Systems, Japan, acquired Dutch medical equipment manufacturer Fysicon B.V.

In April 2018, private equity firm Veritas Capital acquired healthcare technology unit of General Electric, the U.S.
Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more